Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

33.50p
   
  • Change Today:
      0.20p
  • 52 Week High: 56.80
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 1,528,325
  • Market Cap: £181.03m
  • RiskGrade: 119

Latest ShareCast News

Butterfield out, Sedgwick in as Alliance Pharma CEO

By Josh White

Date: Wednesday 08 May 2024

(Sharecast News) - Alliance Pharma announced a significant leadership transition on Wednesday, with chief executive Peter Butterfield stepping down from his role to pursue other business interests.

Alliance Pharma ShareCast News

Alliance Pharma delays preliminary results 22-Apr-2024 ShareCast
Alliance Pharma to delay release of 2023 results 05-Apr-2024 ShareCast
Alliance Pharma names Camillo Pane as chair 05-Feb-2024 ShareCast
RBC Capital Markets nudges down Alliance Pharma ... 31-Jan-2024 ShareCast
Alliance Pharma expects no profit growth in 2024 29-Jan-2024 ShareCast

Alliance Pharma Regulatory News

Notification of Major Holdings 12-Jun-2024 17:57 RNS
Notification of Major Holdings 12-Jun-2024 14:56 RNS
Notification of Major Holdings 12-Jun-2024 14:45 RNS
Notification of Major Holdings 05-Jun-2024 12:35 RNS
Notification of Major Holdings 30-May-2024 12:00 RNS

Alliance Pharma Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Alliance Pharma Tips & Analysis

Investment Column : Alliance Pharma 09-Sep-2010 The Independent
Investment Column:Alliance Pharma 19-Mar-2009 The Independent
Market report: Thursday latest 13-Sep-2007 Daily Mail
Gloomy summer casts shadow over Next 10-Sep-2007 The Independent

Alliance Pharma News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 33.50p
Change Today 0.20p
% Change 0.60 %
52 Week High 56.80
52 Week Low 29.35
Volume 1,528,325
Shares Issued 540.40m
Market Cap £181.03m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.47% above the market average94.47% above the market average94.47% above the market average94.47% above the market average94.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
74.91% below the market average74.91% below the market average74.91% below the market average74.91% below the market average74.91% below the market average
16.98% below the sector average16.98% below the sector average16.98% below the sector average16.98% below the sector average16.98% below the sector average
Income
35.94% above the market average35.94% above the market average35.94% above the market average35.94% above the market average35.94% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
89.14% below the market average89.14% below the market average89.14% below the market average89.14% below the market average89.14% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 14-Jun-2024

Time Volume / Share Price
16:36 47,761 @ 33.50p
16:35 69,838 @ 33.50p
16:35 14,367 @ 33.50p
16:35 7,201 @ 33.50p
16:35 11,656 @ 33.50p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page